Media | Ascentacap

AbbVie pays ADARx $335M cash for next-gen siRNA options

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C

October 23, 2024

OrsoBio Announces Oversubscribed $67 Million Series B to Accelerate Obesity and Metabolic Portfolio

September 06, 2024

Cardurion Builds Cardiovascular Pipeline with $260M Series B Financing

Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund

Cardurion Pharmaceuticals Announces $260 Million Series B Financing to Advance Its Pipeline....

How two academic chemists turned San Diego startup Iambic into an AI force

Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs

NVIDIA GTC 2024 -- Official Keynote Intro

Iambic Therapeutics Announces New Research Published in Nature Machine Intelligence

February 12, 2024

Odyssey raises epic $101M to push programs off to clinical sea

December 5, 2023

Odyssey Therapeutics Announces $101 Million Series C Financing

December 05, 2023

Gary Glick’s Odyssey raises $101M Series C as first immunology drugs approach the clinic

December 5, 2023

Iambic ups rhythm in AI-enabled race to clinic, revealing $100M round and Nvidia pact

October 4 , 2023

Iambic Therapeutics Announces Close of Oversubscribed $100 Million Series B Financing to Advance AI-Discovered.

October 3, 2023

Fresh off massive fundraising, ADARx preps 3rd clinical program and mulls IPO.

October 3, 2023

Adarx to use $200M in financing to advance its clinical programs.

August 21, 2023

ADARx secures $200m to advance clinical programmes.

August 10, 2023

Jan. 20 Quick Takes: Moderna vets pick ADARx for new VC’s debut investment.

January 21, 2023

ADARx Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Clinical Study of ADX-324.

January 20, 2023

ADARx Pharmaceuticals Raises $46 Million as Lead Product Enters the Clinic.

January 20, 2023